“In Vivo Delivery of Nucleic Acid-Formulated Microparticles as a Potential Tolerogenic Vaccine for Type 1 Diabetes ”, Rev Diabet Stud, vol. 9, no. 4, Aug. 2023, Accessed: Sep. 13, 2025. [Online]. Available: https://diabeticstudies.org/index.php/RDS/article/view/184